Literature DB >> 10430705

Eosinophilic bronchitis is an important cause of chronic cough.

C E Brightling1, R Ward, K L Goh, A J Wardlaw, I D Pavord.   

Abstract

Eosinophilic bronchitis presents with chronic cough and sputum eosinophilia, but without the abnormalities of airway function seen in asthma. It is important to know how commonly eosinophilic bronchitis causes cough, since in contrast to cough in patients without sputum eosinophilia, the cough responds to inhaled corticosteroids. We investigated patients referred over a 2-yr period with chronic cough, using a well-established protocol with the addition of induced sputum in selected cases. Eosinophilic bronchitis was diagnosed if patients had no symptoms suggesting variable airflow obstruction, and had normal spirometric values, normal peak expiratory flow variability, no airway hyperresponsiveness (provocative concentration of methacholine producing a 20% decrease in FEV(1) ([PC(20)] > 8 mg/ml), and sputum eosinophilia (> 3%). Ninety-one patients with chronic cough were identified among 856 referrals. The primary diagnosis was eosinophilic bronchitis in 12 patients, rhinitis in 20, asthma in 16, post-viral-infection status in 12, and gastroesophageal reflux in seven. In a further 18 patients a diagnosis was established. The cause of chronic cough remained unexplained in six patients. In all 12 patients with eosinophilic bronchitis, the cough improved after treatment with inhaled budesonide 400 micrograms twice daily, and in eight of these patients who had a follow-up sputum analysis, the eosinophil count decreased significantly, from 16.8% to 1.6%. We conclude that eosinophilic bronchitis is a common cause of chronic cough, and that sputum induction is important in the investigation of cough.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430705     DOI: 10.1164/ajrccm.160.2.9810100

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  88 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

Review 2.  Cough . 6: Which investigations are most useful in the diagnosis of chronic cough?

Authors:  L P A McGarvey
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

Review 3.  Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.

Authors:  Joan Monés
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

5.  Non-eosinophilic asthma and the innate immune response.

Authors:  Ian D Pavord
Journal:  Thorax       Date:  2007-03       Impact factor: 9.139

Review 6.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

7.  Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

Authors:  C E Brightling; S McKenna; B Hargadon; S Birring; R Green; R Siva; M Berry; D Parker; W Monteiro; I D Pavord; P Bradding
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

Review 8.  Cough. 1: Chronic cough in adults.

Authors:  A H Morice; J A Kastelik
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

9.  Increased Sputum IL-17A Level in Non-asthmatic Eosinophilic Bronchitis.

Authors:  Chen Zhan; Rong Xu; Jiaxing Liu; Shengfang Zhang; Wei Luo; Ruchong Chen; Kefang Lai
Journal:  Lung       Date:  2018-10-01       Impact factor: 2.584

10.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.